Accelerated Restitution of Endothelial Integrity and Endothelium-Dependent Function after phVEGF165 Gene Transfer

Circulation

Volumn 94, Issue 12, 1996, Pages 3291-3302

  Asahara, Takayuki ^a   Chen, Donghui ^a   Tsurumi, Yukio ^a   Kearney, Marianne ^a   Rossow, Susan ^a   Passen, Jonathan ^a   Symes, James F ^a   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Endothelium; Genes; Remodeling

Indexed keywords

PLASMID DNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; BALLOON CATHETER; CELL REGENERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMORAL ARTERY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANGIOPLASTY, BALLOON; ANIMALS; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; HUMANS; LAC OPERON; LYMPHOKINES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; POLYMERASE CHAIN REACTION; RABBITS; RECOMBINANT PROTEINS; REGENERATION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030469543     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3291     Document Type: Article

References (50)

1. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1994;330:981-993.
2. Herman WR, Rensing BJ, Strauss BH, Serruys PW. Prevention of reslenosis after percutaneous transluminal coronary angioplasty: the search for a 'magic bullet.' Am Heart J. 1991;122:171-187.
3. Clowes AW, Collazzo RE, Karnovsky MJ. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invent. 1978;39:141-150.
4. Bjorkerud S, Bondjers G. Arterial repair and atherosclerosis after mechanical injury, part 5: tissue response after induction of a large superficial transverse injury. Atherosclerosis. 1973;18:235-255.
5. Fishman JR, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carolid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest. 1975;32: 339-351.
6. Haudenschild CC, Schwanz SM. Endothelial regeneration. II: restitution of endothelial continuity. Lab Invest. 1979;41:407-418.
7. Ross R, Atherosclerosis: a defense mechanism gone awry. Am J Pathol. 1993;143:985-1002.
8. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851-855.
9. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-1312.
10. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBOJ. 1989;8:3801-3806.
11. Connolly DT, Hewelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel RN. Leimgruber RS, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470-1478.
12. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angtogenic mitogen. Science. 1989;246:1306-1309.
13. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ,. Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
14. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Linger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
15. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993;265:H586-H592.
16. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb following administration of vascular endothelial growth factor. Circulation. 1995;91:2802-2809.
17. Tischer E, Mitchell R, Hartmann T, Suva M, Gospodarowicz D, Fiddes J, Abraham J. The human gene for vascular endolhelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266:11947-11954.
18. Isner JM, Walsh K, Symes JF, Piezcek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 1995;91:2687-2692.
19. Bonnerot C, Rocancourt D, Briand P, Grimber G. A beta-galactosidase hybrid protein targeted to nuclei us a marker for developmental studies. Proc Natl Acad Sci U S A. 1987;84:6795-6799.
20. Takeshita S, Gal D, Leclerc G, Pickering JG, Riessen R, Weir L, Isner JM. Increased gene expression alter liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation following vascular injury. J Clin Invest. 1994;93:652-661.
21. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther. 1993; 4:749-758.
22. LeFree HT, Simon SB, Mancini BJ, Vogel RA. Digital radiographic assessment of coronary arterial geometric diameter and videodesitometric cross-sectional area. Proc SPIE. 1986;626:334-341.
23. Mancini CBJ, Simon SB, McGillem MJ, LeFree MT, Friedman HZ, Vogel RA. Automated quantitative arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation. 1987;75:452-460.
24. Pickering JG, Weir L, Jekanowski J, Kearney MA, Isner JM. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest. 1993;91:1469-1480.
25. Coffin JD, Harrison J, Schwanz S, Heimark R. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol. 1991;148:51 -62.
26. Shimokawa H, Vanhoutte P. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation. 1988;78:1421-1430.
27. Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 1987; 61:256-270.
28. Weidinger FF, McLenachan JM, Cybulsky MI, Bordon JB, Rennke HG, Hollenberg NK, Fallen JT, Ganz P, Cooke JP. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation. 1990;81:1667-1679.
29. Koos RD, Goldman WF. Hypoxia stimulates vascular endothelial growth/permeability factor expression by rat vascular smooth muscle cells. Abstracts of the Scientific Conference on the Molecular Cellular Biolory of the Vascular Wall, Boston, Mass, October 15-17, 1993.
30. Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 1990;85:2004-2008.
31. Winkles JA, Gay CG. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin binding (acidic and basic fibroblast growth factor) gene expression in human vascular smooth muscle cells. Cell Growth Differ. 1991;2:531-540.
32. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991;88:8651-8655.
33. Asahara T, Bauters C, Pastore CJ, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793-2801.
34. Steele PM, Chesebro JH, Stanton AW, Holmes DR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: natural history of the pathophysiological response lo injury in a pig model. Circ Res. 1985;57:105-112.
35. Tanaka H, Sukhona GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P, Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 1993;33:1788-1803.
36. Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 1988;60:459-464.
37. Schwarz TH, Yates ON, Ghobrial M, Baker WH. Pathologic characteristics of recurrent carotid artery stenosis. J Vasc Surg. 1987; 5:280-288.
38. Gravanis MB, Roubin GS. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis. Hum Pathol. 1989;20:477-485.
39. Chang MW, Barr E, Jonathan S, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
40. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A. 1994;91:10732-10736.
41. Heiko E, Leyen VD, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
42. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 1994;265:781-784.
43. Losordo DW, Pickering JG, Takeshita S, Leclerc G, Gal D, Weir L, Kearney M, Jekanowski J, Isner JM. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation. 1994;89:785-792.
44. Takeshita S, Losordo DW, Kearney M, Isner JM. Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab Invest. 1994; 71:387-391.
45. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ. Direct gene transfer of transforming growth factor beta-1 into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90:10759-10763.
46. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 1993;91:1822-1829.
47. Wight T, Curwen K, Litrenta MM, Alonso DR, Minick CR. Effect of endothelium on glycosaminoglycan accumulation in injured rabbit aorta. Am J Pathol. 1983;113:156-164.
48. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A. 1993;90:8915-8919.
49. Connolly DR, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J. Human vascular permeability factor: isolation from U937 cells. J Biol Chem. 1989;264: 20017-20024.
50. Asahara T, Bauters C, Wu T, Chen D, Zhen LP, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Restoration of endothelial function in hypercholesterolemic rabbit by intermittent administration of vascular endothelial growth factor. J Am Coll Cordial. 1995;25:366A.